CURRENT
ISSUE1622
April 19, 2021
The choice of drugs for treatment of allergic rhinitis
depends on the severity of symptoms and whether
they are are intermittent or persistent (see Table 1). read more...
More from issue 1622
Advance Release
Coming Soon
Vibegron (Gemtesa) for Overactive Bladder
Fluvoxamine for COVID-19?
Evinacumab (Evkeeza) for Homozygous Familial Hypercholesterolemia
Tirbanibulin (Klisyri) for Actinic Keratosis
Recommend to Your Library
Previous Issues
April 5, 2021 (1621)
- An EUA for Bamlanivimab and Etesevimab for COVID-19
- Oriahnn for Fibroid-Associated Heavy Menstrual Bleeding
- Semaglutide (Ozempic) for Weight Loss
- Low-Dose Colchicine for Coronary Artery Disease
- In Brief: Hypertension with Erenumab (Aimovig)
- Ripretinib (Qinlock) for GIST (online only)
- COVID-19 Vaccine Comparison Chart (online only)
March 22, 2021 (1620)
- FDA Authorizes Johnson & Johnson COVID-19 Vaccine
- Drugs for Multiple Sclerosis
- Stiripentol (Diacomit) for Dravet Syndrome (online only)
March 8, 2021 (1619)
- Sodium Sulfate-Based Tablets (Sutab) for Colonoscopy Preparation
- Vericiguat (Verquvo) for Heart Failure
- Oliceridine (Olinvyk) - A New Opioid for Severe Pain
- Ashwagandha Supplements
- Comparison Table: Some Drugs for HFrEF (online only)
- Lanadelumab (Takhzyro) for Prevention of Hereditary Angioedema (online only)
- In Brief: Phesgo - A Fixed-Dose Combination for HER-2 Positive Breast Cancer (online only)
February 22, 2021 (1618)
February 8, 2021 (1617)
